Tag : NASH

AI/ML

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials.

Newsemia
Related Articles An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials. Diagnostics (Basel). 2020 Aug 28;10(9): Authors: Leow WQ,...
Latest News

LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions

Newsemia
SEOUL, South Korea & NANJING, China–(BUSINESS WIRE)– #NASH–LG Chem enters an exclusive license agreement with TransThera for development and commercialization of TransThera’s TT-01025. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World